Melanie Royce
11PUBLICATIONS
60CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Aug 27, 2025
FDA Approval Summary: Datopotamab Deruxtecan-dlnk for Treatment of Patients with Unresectable or Metastatic, HR-Positive, HER2-Negative Breast Cancer.Melanie Royce, Mirat Shah, Lijun Zhang
|Oct 08, 2024
FDA Approval Summary: Capecitabine Labeling Update under Project Renewal.Sundeep Agrawal, Clara Lee, William F Pierce
|Apr 27, 2023
US Food and Drug Administration Expanded Adjuvant Indication of Abemaciclib in High-Risk Early Breast Cancer.Melanie Royce, Flora Mulkey, Christy Osgood
|Jan 27, 2022
FDA Approval Summary: Abemaciclib With Endocrine Therapy for High-Risk Early Breast Cancer.Melanie Royce, Christy Osgood, Flora Mulkey
|Dec 17, 2021
FDA Approval Summary: Margetuximab plus Chemotherapy for Advanced or Metastatic HER2-Positive Breast Cancer.Melanie Royce, Christy L Osgood, Anup K Amatya
|Oct 29, 2021
U.S. FDA Drug Approvals for Breast Cancer: A Decade in Review.Shaily Arora, Preeti Narayan, Christy L Osgood
Pageof 2
Frequent Collaborators
4 joint publications
Laleh Amiri-Kordestani
3 joint publications
Jennifer J Gao
3 joint publications
Richard Pazdur
2 joint publications
Flora Mulkey
2 joint publications
Amna Ibrahim
2 joint publications
Tatiana M Prowell
2 joint publications
Shenghui Tang
2 joint publications
Kirsten B Goldberg
2 joint publications
Suparna Wedam
2 joint publications
Eric R Prossnitz
